Milong Su
Quanzhou, 362000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion.
Journal: Nature communications
Published: November 27, 2022
Decreased frequency of a novel T-lymphocyte subset, CD3+ CD4- CD7+ CD57- T cells, in hepatitis B virus-related end-stage liver disease might contribute to disease progression.
Journal: Journal of medical virology
Published: July 07, 2022
The Association of Human Leukocyte Antigen and COVID-19 in Southern China.
Journal: Open forum infectious diseases
Published: March 12, 2021
A Retrospective Study of the Epidemiologic and Clinical Characteristics of COVID-19 Among Hospitalized Patients in Quanzhou, China.
Journal: Infectious microbes & diseases
Published: October 28, 2020
Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure.
Journal: Medicine
Published: April 22, 2016
The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
Journal: Clinical and vaccine immunology : CVI
Published: October 07, 2014
Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
Journal: Journal of gastroenterology and hepatology
Published: November 03, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026